Detalhe da pesquisa
1.
Impact of radiological response and pattern of progression in patients with HCC treated by atezolizumab-bevacizumab.
Hepatology
; 79(1): 49-60, 2024 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37870270
2.
Integration of new technologies in the multidisciplinary approach to primary liver tumours: The next-generation tumour board.
J Hepatol
; 2024 Jun 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38871125
3.
Indolent cancer and pattern of progression: Two missing parameters in trial design for hepatology.
Hepatology
; 2023 Jul 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37399245
4.
Body weight changes and duration of estrogen exposure modulate the evolution of hepatocellular adenomas after contraception discontinuation.
Hepatology
; 77(2): 430-442, 2023 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35980227
5.
No correlation between MASLD and poor outcome of Atezolizumab-Bevacizumab therapy in patients with advanced HCC.
Liver Int
; 44(4): 931-943, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38291735
6.
Long-term oncological results of percutaneous radiofrequency ablation for intrahepatic cholangiocarcinoma.
Liver Int
; 44(6): 1363-1372, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38436538
7.
Upfront multi-bipolar radiofrequency ablation for HCC in transplant-eligible cirrhotic patients with salvage transplantation in case of recurrence.
Liver Int
; 44(6): 1464-1473, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38581233
8.
Incidence and clinical impact of bile ducts changes after multibipolar radiofrequency ablation for hepatocellular carcinoma.
Eur Radiol
; 2024 Feb 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38334763
9.
Artificial intelligence-based pathology as a biomarker of sensitivity to atezolizumab-bevacizumab in patients with hepatocellular carcinoma: a multicentre retrospective study.
Lancet Oncol
; 24(12): 1411-1422, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37951222
10.
Molecular-based targeted therapies in patients with hepatocellular carcinoma and hepato-cholangiocarcinoma refractory to atezolizumab/bevacizumab.
J Hepatol
; 79(6): 1450-1458, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37647991
11.
Baseline ALBI score and early variation of serum AFP predicts outcomes in patients with HCC treated by atezolizumab-bevacizumab.
Liver Int
; 43(3): 708-717, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36444741
12.
ERS: A simple scoring system to predict early recurrence after surgical resection for hepatocellular carcinoma.
Liver Int
; 43(11): 2538-2547, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37577984
13.
Impact of COVID-19 on the management of hepatocellular carcinoma in a high-prevalence area: What's new 12 months later?
Ann Hepatol
; 28(6): 101141, 2023 Jul 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37468096
14.
Hepatitis B virus integrations promote local and distant oncogenic driver alterations in hepatocellular carcinoma.
Gut
; 71(3): 616-626, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33563643
15.
Common genetic variation in alcohol-related hepatocellular carcinoma: a case-control genome-wide association study.
Lancet Oncol
; 23(1): 161-171, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34902334
16.
Biomarkers for Hepatobiliary Cancers.
Hepatology
; 73 Suppl 1: 115-127, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32045030
17.
DNA Methylation Signatures Reveal the Diversity of Processes Remodeling Hepatocellular Carcinoma Methylomes.
Hepatology
; 74(2): 816-834, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33713365
18.
Liver Stiffness by Transient Elastography to Detect Porto-Sinusoidal Vascular Liver Disease With Portal Hypertension.
Hepatology
; 74(1): 364-378, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33345307
19.
Combination of Model for End-Stage Liver Disease and Lactate Predicts Death in Patients Treated With Salvage Transjugular Intrahepatic Portosystemic Shunt for Refractory Variceal Bleeding.
Hepatology
; 74(4): 2085-2101, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34018627
20.
Performance of non-invasive biomarkers compared with invasive methods for risk prediction of posthepatectomy liver failure in hepatocellular carcinoma.
Br J Surg
; 109(5): 455-463, 2022 04 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-35141742